Glycovax Pharma

Glycovax Pharma, established in 2016, is a Canadian biopharmaceutical company dedicated to the design and development of key technologies for next-generation human and veterinary conjugate vaccines. With its unique expertise in glycoimmunology, Glycovax Pharma positions itself at the forefront of more effective vaccine solutions, particularly in the fields of viral or bacterial infections and cancer.